Pain after breast cancer surgery may be associated with underlying depression
the ONA take:
Depression may increase the intensity of postoperative acute pain in women with breast cancer, according to a new study published online ahead of print in the journal Psycho-Oncology.
For the study, researchers sought to determine the prevalence of severe, definite depression symptoms among patients with breast cancer and to assess the association between severe depression symptoms and sociodemographic and perioperative factors during the perioperative period.
Researchers analyzed data from 1,499 women with breast cancer who were admitted for definitive breast surgery. Results showed that 2 or more family members with cancer, having a prescription for sedative medication, and persistent, severe pain during the postoperative period were significantly associated with severe, definite depression symptoms.
The findings suggest that self-reporting of persistent postoperative pain intensity among patients with breast cancer may be useful in identifying hidden depression symptoms during the perioperative period.
Depression may increase the intensity of postoperative acute pain in women with breast cancer.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|